David Suhy, PhD, the cofounder and chief scientific officer at Earli, discussed the company’s unique approach to cancer diagnosis.
David Suhy, PhD
Advertisement
Articles by David Suhy, PhD
The cofounder and chief scientific officer at Earli discussed the company’s unique approach to cancer diagnosis.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
PreBLA Meeting With FDA Sinks uniQure’s Hopes for Approval of Huntington Disease Gene Therapy AMT-130 Based Primarily on Phase 1/2 Data
2
FDA Activity Recap: October 2025 Features New Platform Technology Designation, RDEA Pilot Program Selection, and More
3
